» Articles » PMID: 35628202

Increase in Mitochondrial D-Loop Region Methylation Levels in Mild Cognitive Impairment Individuals

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 May 28
PMID 35628202
Authors
Affiliations
Soon will be listed here.
Abstract

Methylation levels of the mitochondrial displacement loop (D-loop) region have been reported to be altered in the brain and blood of Alzheimer's disease (AD) patients. Moreover, a dynamic D-loop methylation pattern was observed in the brain of transgenic AD mice along with disease progression. However, investigations on the blood cells of AD patients in the prodromal phases of the disease have not been performed so far. The aim of this study was to analyze D-loop methylation levels by means of the MS-HRM technique in the peripheral blood cells of 14 mild cognitive impairment (MCI) patients, 18 early stage AD patients, 70 advanced stage AD patients, and 105 healthy control subjects. We found higher D-loop methylation levels in MCI patients than in control subjects and AD patients. Moreover, higher D-loop methylation levels were observed in control subjects than in AD patients in advanced stages of the disease, but not in those at early stages. The present pilot study shows that peripheral D-loop methylation levels differ in patients at different stages of AD pathology, suggesting that further studies deserve to be performed in order to validate the usefulness of D-loop methylation analysis as a peripheral biomarker for the early detection of AD.

Citing Articles

Mitochondrial DNA (mtDNA) as fluid biomarker in neurodegenerative disorders: A systematic review.

Risi B, Imarisio A, Cuconato G, Padovani A, Valente E, Filosto M Eur J Neurol. 2025; 32(1):e70014.

PMID: 39831374 PMC: 11744304. DOI: 10.1111/ene.70014.


Exposure to Metals, Pesticides, and Air Pollutants: Focus on Resulting DNA Methylation Changes in Neurodegenerative Diseases.

Stoccoro A, Coppede F Biomolecules. 2024; 14(11).

PMID: 39595543 PMC: 11591912. DOI: 10.3390/biom14111366.


Associations between Circulating Biomarkers of One-Carbon Metabolism and Mitochondrial D-Loop Region Methylation Levels.

Stoccoro A, Lari M, Migliore L, Coppede F Epigenomes. 2024; 8(4).

PMID: 39449362 PMC: 11503383. DOI: 10.3390/epigenomes8040038.


Mitochondrial One-Carbon Metabolism and Alzheimer's Disease.

Yu Y, Martins L Int J Mol Sci. 2024; 25(12).

PMID: 38928008 PMC: 11203557. DOI: 10.3390/ijms25126302.


Integrating mitoepigenetics into research in mood disorders: a state-of-the-art review.

Ceylan D, Arat-Celik H, Aksahin I Front Physiol. 2024; 15:1338544.

PMID: 38410811 PMC: 10895490. DOI: 10.3389/fphys.2024.1338544.


References
1.
Stoccoro A, Siciliano G, Migliore L, Coppede F . Decreased Methylation of the Mitochondrial D-Loop Region in Late-Onset Alzheimer's Disease. J Alzheimers Dis. 2017; 59(2):559-564. DOI: 10.3233/JAD-170139. View

2.
Li L, Dahiya R . MethPrimer: designing primers for methylation PCRs. Bioinformatics. 2002; 18(11):1427-31. DOI: 10.1093/bioinformatics/18.11.1427. View

3.
Albert M, DeKosky S, Dickson D, Dubois B, Feldman H, Fox N . The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3):270-9. PMC: 3312027. DOI: 10.1016/j.jalz.2011.03.008. View

4.
Wang W, Zhao F, Ma X, Perry G, Zhu X . Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances. Mol Neurodegener. 2020; 15(1):30. PMC: 7257174. DOI: 10.1186/s13024-020-00376-6. View

5.
Maity S, Farrell K, Navabpour S, Narayanan S, Jarome T . Epigenetic Mechanisms in Memory and Cognitive Decline Associated with Aging and Alzheimer's Disease. Int J Mol Sci. 2021; 22(22). PMC: 8618067. DOI: 10.3390/ijms222212280. View